Abstract
This study uses data from January/Q1 2022 Medicare Prescription Drug Plan Formulary files to compare premiums and total spending for users of long-acting insulin who selected prescription drug plans in 2022 and to estimate potential savings for beneficiaries who selected Senior Savings model-participating plans.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
